165 related articles for article (PubMed ID: 15299078)
1. Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells.
Rinne M; Caldwell D; Kelley MR
Mol Cancer Ther; 2004 Aug; 3(8):955-67. PubMed ID: 15299078
[TBL] [Abstract][Full Text] [Related]
2. N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.
Tang JB; Svilar D; Trivedi RN; Wang XH; Goellner EM; Moore B; Hamilton RL; Banze LA; Brown AR; Sobol RW
Neuro Oncol; 2011 May; 13(5):471-86. PubMed ID: 21377995
[TBL] [Abstract][Full Text] [Related]
3. Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide.
Fishel ML; He Y; Smith ML; Kelley MR
Clin Cancer Res; 2007 Jan; 13(1):260-7. PubMed ID: 17200364
[TBL] [Abstract][Full Text] [Related]
4. N-methylpurine DNA glycosylase inhibits p53-mediated cell cycle arrest and coordinates with p53 to determine sensitivity to alkylating agents.
Song S; Xing G; Yuan L; Wang J; Wang S; Yin Y; Tian C; He F; Zhang L
Cell Res; 2012 Aug; 22(8):1285-303. PubMed ID: 22801474
[TBL] [Abstract][Full Text] [Related]
5. Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing.
Fishel ML; Seo YR; Smith ML; Kelley MR
Cancer Res; 2003 Feb; 63(3):608-15. PubMed ID: 12566303
[TBL] [Abstract][Full Text] [Related]
6. Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide.
Trivedi RN; Wang XH; Jelezcova E; Goellner EM; Tang JB; Sobol RW
Mol Pharmacol; 2008 Aug; 74(2):505-16. PubMed ID: 18477668
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of hPMC2 imparts chemotherapeutic sensitivity to alkylating agents in breast cancer cells.
Krishnamurthy N; Liu L; Xiong X; Zhang J; Montano MM
Cancer Biol Ther; 2015; 16(4):518-27. PubMed ID: 25849309
[TBL] [Abstract][Full Text] [Related]
8. N-methylpurine DNA glycosylase overexpression increases alkylation sensitivity by rapidly removing non-toxic 7-methylguanine adducts.
Rinne ML; He Y; Pachkowski BF; Nakamura J; Kelley MR
Nucleic Acids Res; 2005; 33(9):2859-67. PubMed ID: 15905475
[TBL] [Abstract][Full Text] [Related]
9. ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents.
Agnihotri S; Burrell K; Buczkowicz P; Remke M; Golbourn B; Chornenkyy Y; Gajadhar A; Fernandez NA; Clarke ID; Barszczyk MS; Pajovic S; Ternamian C; Head R; Sabha N; Sobol RW; Taylor MD; Rutka JT; Jones C; Dirks PB; Zadeh G; Hawkins C
Cancer Discov; 2014 Oct; 4(10):1198-213. PubMed ID: 25100205
[TBL] [Abstract][Full Text] [Related]
10. [Effect of adenoviral N-methylpurine DNA glycosylase overexpression on chemosensitivity of human osteosarcoma cells].
Wang D; Zhong ZY; Zhang QH; Li ZP; Kelley MR
Zhonghua Bing Li Xue Za Zhi; 2006 Jun; 35(6):352-6. PubMed ID: 16834910
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with temozolomide and methoxyamine: blocking apurininc/pyrimidinic site repair coupled with targeting topoisomerase IIalpha.
Yan L; Bulgar A; Miao Y; Mahajan V; Donze JR; Gerson SL; Liu L
Clin Cancer Res; 2007 Mar; 13(5):1532-9. PubMed ID: 17332299
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.
Liu L; Taverna P; Whitacre CM; Chatterjee S; Gerson SL
Clin Cancer Res; 1999 Oct; 5(10):2908-17. PubMed ID: 10537360
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of human carcinoma cells to alkylating agents by small interfering RNA suppression of 3-alkyladenine-DNA glycosylase.
Paik J; Duncan T; Lindahl T; Sedgwick B
Cancer Res; 2005 Nov; 65(22):10472-7. PubMed ID: 16288039
[TBL] [Abstract][Full Text] [Related]
14. A novel fluorometric oligonucleotide assay to measure O( 6)-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase.
Kreklau EL; Limp-Foster M; Liu N; Xu Y; Kelley MR; Erickson LC
Nucleic Acids Res; 2001 Jun; 29(12):2558-66. PubMed ID: 11410664
[TBL] [Abstract][Full Text] [Related]
15. Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds.
Tentori L; Turriziani M; Franco D; Serafino A; Levati L; Roy R; Bonmassar E; Graziani G
Leukemia; 1999 Jun; 13(6):901-9. PubMed ID: 10360379
[TBL] [Abstract][Full Text] [Related]
16. The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death.
Trivedi RN; Almeida KH; Fornsaglio JL; Schamus S; Sobol RW
Cancer Res; 2005 Jul; 65(14):6394-400. PubMed ID: 16024643
[TBL] [Abstract][Full Text] [Related]
17. Alkylation sensitivity screens reveal a conserved cross-species functionome.
Svilar D; Dyavaiah M; Brown AR; Tang JB; Li J; McDonald PR; Shun TY; Braganza A; Wang XH; Maniar S; St Croix CM; Lazo JS; Pollack IF; Begley TJ; Sobol RW
Mol Cancer Res; 2012 Dec; 10(12):1580-96. PubMed ID: 23038810
[TBL] [Abstract][Full Text] [Related]
18. Effects of substrate specificity on initiating the base excision repair of N-methylpurines by variant human 3-methyladenine DNA glycosylases.
Connor EE; Wilson JJ; Wyatt MD
Chem Res Toxicol; 2005 Jan; 18(1):87-94. PubMed ID: 15651853
[TBL] [Abstract][Full Text] [Related]
19. C1q/TNF-related peptide 8 (CTRP8) promotes temozolomide resistance in human glioblastoma.
Thanasupawat T; Glogowska A; Burg M; Krcek J; Beiko J; Pitz M; Zhang GJ; Hombach-Klonisch S; Klonisch T
Mol Oncol; 2018 Sep; 12(9):1464-1479. PubMed ID: 29949238
[TBL] [Abstract][Full Text] [Related]
20. Altering DNA base excision repair: use of nuclear and mitochondrial-targeted N-methylpurine DNA glycosylase to sensitize astroglia to chemotherapeutic agents.
Harrison JF; Rinne ML; Kelley MR; Druzhyna NM; Wilson GL; Ledoux SP
Glia; 2007 Nov; 55(14):1416-25. PubMed ID: 17674369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]